Table of Contents
International Scholarly Research Notices
Volume 2014, Article ID 385969, 22 pages
http://dx.doi.org/10.1155/2014/385969
Review Article

Ethnopharmacological Significance of Eclipta alba (L.) Hassk. (Asteraceae)

1Department of Biotechnology & Genetic Engineering, University of Development Alternative, Dhanmondi, Dhaka 1209, Bangladesh
2Department of Pharmacy, University of Development Alternative, Dhanmondi, Dhaka 1209, Bangladesh
3Department of Microbiology and Serology, NH Health, Bangalore 560099, India
4Faculty of Life Sciences, University of Development Alternative, House No. 78, Road No. 11A (new), Dhanmondi, Dhaka 1209, Bangladesh

Received 29 June 2014; Accepted 8 September 2014; Published 29 October 2014

Academic Editor: Jagadananda Ghosh

Copyright © 2014 Rownak Jahan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. P. Khare, Indian Medicinal Plants: An Illustrated Dictionary, Springer, Berlin, Germany, 2007.
  2. N. M. Mithun, S. Shashidhara, and R. Vivek Kumar, “Eclipta alba (L.) A review on its phytochemical and pharmacological profile,” Pharmacologyonline, vol. 1, pp. 345–357, 2011. View at Google Scholar
  3. K. Ma-Ma, N. Nyunt, and K. M. Tin, “The protective effect of Eclipta alba on carbon tetrachloride-induced acute liver damage,” Toxicology and Applied Pharmacology, vol. 45, no. 3, pp. 723–728, 1978. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Wagner, B. Geyer, Y. Kiso, H. Hikino, and G. S. Rao, “Coumestans as the main active principles of the liver drugs Eclipta alba and Wedelia calendulacea,” Planta Medica, vol. 5, pp. 370–374, 1986. View at Google Scholar · View at Scopus
  5. V. N. Murthy, B. P. Reddy, V. Venkateshwarlu, and C. K. Kokate, “Antihepatotoxic activity of Eclipta alba, Tephrosia purpurea and Boerhaavia diffusa,” Ancient Science of Life, vol. 11, pp. 182–186, 1992. View at Google Scholar
  6. R. K. Upadhyay, M. B. Pandey, R. N. Jha, and V. B. Pandey, “Eclalbatin, a triterpene saponin from Eclipta alba,” Journal of Asian Natural Products Research, vol. 3, no. 3, pp. 213–217, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Zhang, Y. Y. Chen, X. H. Di, and M. Liu, “Isolation and identification of ecliptasaponin D from Eclipta alba (L.) hassk,” Yao Xue Xue Bao, vol. 32, no. 8, pp. 633–634, 1997. View at Google Scholar · View at Scopus
  8. M. Zhang and Y. Chen, “Chemical constituents of Eclipta alba (L.) Hassk,” Zhongguo Zhong Yao Za Zhi, vol. 21, no. 8, pp. 480–510, 1996. View at Google Scholar · View at Scopus
  9. A. V. Khan and A. A. Khan, “Ethnomedicinal uses of Eclipta prostrta Linn,” Indian Journal of Traditional Knowledge, vol. 7, no. 2, pp. 316–320, 2008. View at Google Scholar · View at Scopus
  10. A. Gautam and A. Batra, “Ethnomedicinal plant product used by the local traditional practitioners in Mount Abu,” World Journal of Pharmaceutical Sciences, vol. 1, no. 1, pp. 10–18, 2012. View at Publisher · View at Google Scholar
  11. K. Hussain, M. F. Nisar, A. Majeed, K. Nawaz, and K. H. Bhatti, “Ethnomedicinal survey for important plants of Jalalpur Jattan, District Gujrat, Punjab, Pakistan,” Ethnobotanical Leaflets, vol. 14, pp. 807–825, 2010. View at Google Scholar
  12. M. Rahmatullah, M. A. H. Mollik, A. T. M. A. Azam et al., “Ethnobotanical survey of the Santal tribe residing in Thakurgaon District, Bangladesh,” American-Eurasian Journal of Sustainable Agriculture, vol. 3, no. 4, pp. 889–898, 2009. View at Google Scholar
  13. W. Ahmad, A. Hasan, I. Ahmad, and F. Zeenat, “Ethnomedicinal plants of Mansoora, Malegaon,” Hamdard Medicus, vol. 54, pp. 29–40, 2011. View at Google Scholar
  14. S. Das, M. D. Choudhury, S. C. Mandal, and A. D. Talukdar, “Traditional knowledge of ethnomedicinal hepatoprotective plants used by certain ethnic communities of Tripura State,” Indian Journal of Fundamental and Applied Life Sciences, vol. 2, pp. 84–97, 2012. View at Google Scholar
  15. B. B. S. Kapoor and M. Sharma, “Ethnomedicinal aspects of some medicinal plants of Hanumangarh District of Rajasthan,” Journal of Pharmaceutical and Biological Sciences, vol. 1, pp. 7–9, 2013. View at Google Scholar
  16. A. Sharma, M. S. Sharma, A. Mishra, S. Sharma, B. Kumar, and A. Bhandari, “A review on Thar plants used in liver diseases,” International Journal of Research in Pharmacy and Chemistry, vol. 1, pp. 224–236, 2011. View at Google Scholar
  17. V. Kumar and P. K. Singh, “Ethnomedicinal plants used as antidote for snake-bite and scorpion-sting in Bundelkhand (U.P.), India,” IOSR Journal of Environmental Science, Toxicology and Food Technology, vol. 8, no. 1, pp. 52–55, 2014. View at Google Scholar
  18. B. L. Bhellum and S. Singh, “Ethnomedicinal plants of district Samba of Jammu and Kashmir State (List-II),” International Journal of Scientific and Research Publications, vol. 2, pp. 1–8, 2012. View at Google Scholar
  19. M. Rahmatullah, M. A. H. Mollik, A. K. Paul et al., “A comparative analysis of medicinal plants used to treat gastrointestinal disorders in two sub-districts of greater Khulna division, Bangladesh,” Advances in Natural and Applied Sciences, vol. 4, no. 1, pp. 22–28, 2010. View at Google Scholar · View at Scopus
  20. A. N. Korpenwar, “Ethnomedicinal plants used by the tribal's in cure of wounds in Buldhana District (MS) India,” International Journal of Recent Trends in Science and Technology, vol. 3, pp. 49–53, 2012. View at Google Scholar
  21. D. Vaidyanathan, M. S. S. Senthilkumar, and M. G. Basha, “Studies on ethnomedicinal plants used by Malayali tribals in Kolli Hills of Eastern Ghats, Tamil Nadu, India,” Asian Journal of Plant Science & Research, vol. 3, pp. 29–45, 2013. View at Google Scholar
  22. B. C. David and G. Sudarsanam, “Ethnomedicinal plant knowledge and practice of people of Javadhu hills in Tamilnadu,” Asian Pacific Journal of Tropical Biomedicine, vol. 1, no. 1, pp. S79–S81, 2011. View at Google Scholar · View at Scopus
  23. S. Sudeesh, “Ethnomedicinal plants used by Malayaraya tribes of Vannapuram village in Idukki, Kerala, India,” Indian Journal of Scientific Research and Technology, vol. 1, pp. 7–11, 2012. View at Google Scholar
  24. K. Das and P. Duarah, “Traditional knowledge of the women’s of Kaibarta community of Assam about the application of phyto-remedies in certain common childhood diseases,” International Research Journal of Biological Sciences, vol. 3, pp. 57–63, 2014. View at Google Scholar
  25. M. F. Nisar, S. Ismail, M. Arshad, A. Majeed, and M. Arfan, “Ethnomedicinal flora of District Mandi Bahauddin, Pakistan,” Middle-East Journal of Scientific Research, vol. 9, pp. 233–238, 2011. View at Google Scholar
  26. D. F. Malan and D. F. R. Neuba, “Traditional practices and medicinal plants use during pregnancy by Anyi-Ndenye women (Eastern Côte d'Ivoire),” African Journal of Reproductive Health, vol. 15, no. 1, pp. 85–93, 2011. View at Google Scholar · View at Scopus
  27. S. S. Abujam and R. K. Shah, “Study on the ethnomedicinal system of local people of Dibrugarh, Assam,” International Journal of Pharmaceutical Innovation, vol. 2, pp. 17–28, 2012. View at Google Scholar
  28. R. K. Singh and A. Singh, “Women's wisdom and indigenous human healthcare practices,” Indian Journal of Traditional Knowledge, vol. 8, no. 2, pp. 262–269, 2009. View at Google Scholar · View at Scopus
  29. P. Sudhakar and J. Shashikanth, “Ethnomedicinal importance of some weeds grown in sugarcane crop fields of Nizamabad District, Andhra Pradesh, India,” Life Sciences Leaflets, vol. 10, pp. 51–55, 2012. View at Google Scholar
  30. R. Sivaranjani and K. Ramakrishnan, “Traditional uses of medicinal plants in treating skin diseases in Nagapattinam District of Tamil Nadu, India,” International Research Journal of Pharmacy, vol. 3, pp. 201–204, 2012. View at Google Scholar
  31. N. R. Chakraborty and B. Duary, “Utilization of some weeds as medicine by the local people in Birbhum District of West Bengal, India,” International Journal of Bio-resource and Stress Management, vol. 5, pp. 148–152, 2014. View at Google Scholar
  32. M. Panghal, V. Arya, S. Yadav, S. Kumar, and J. P. Yadav, “Indigenous knowledge of medicinal plants used by Saperas community of Khetawas, Jhajjar District, Haryana, India,” Journal of Ethnobiology and Ethnomedicine, vol. 6, article 4, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. A. V. Khan, Q. U. Ahmed, M. W. Khan, and A. A. Khan, “Herbal cure for poisons and poisonous bites from Western Uttar Pradesh, India,” Asian Pacific Journal of Tropical Disease, vol. 4, no. 1, pp. S116–S120, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. L. J. Landge and A. T. Kalse, “Indigenous herbal medicines used by tribal people in Satpuda Mountai,” International Scientific Journal, vol. 1, pp. 65–69, 2014. View at Google Scholar
  35. S. M. Simon, T. S. J. Norman, K. Suresh, and V. Ramachandran, “Ethnomedicinal plants used by the Uraly tribes of Idukki District, Kerala which are hitherto unreported in codified Ayurveda system of medicine,” International Journal of Research in Ayurveda and Pharmacy, vol. 2, pp. 469–472, 2011. View at Google Scholar
  36. N. Agnihotri and A. K. Gupta, “Folklore medicines for cuts and wounds in Kalyanpur block of Kanpur District, Uttar Pradesh, India,” PhTechMed, vol. 2, pp. 381–386, 2013. View at Google Scholar
  37. R. C. Tewari, M. Kotecha, A. K. Sharma, and P. Sharma, “Ethno-medicinal heritage of Chandi Devi Hill’s of Haridwar, Uttarakhand,” International Journal of Innovative Research and Development, vol. 2, pp. 233–241, 2013. View at Google Scholar
  38. K. Yesodharan and K. A. Sujana, “Status of ethnomedicinal plants in the Parambikulam Wildlife Sanctuary, Kerala, South India,” Annals of Forestry, vol. 15, no. 2, pp. 322–334, 2007. View at Google Scholar
  39. B. D. Vashistha and M. Kaur, “Floristic and ethno botanical survey of Ambala District, Haryana,” International Journal of Pharma and Bio Sciences, vol. 4, no. 2, pp. P353–P360, 2013. View at Google Scholar · View at Scopus
  40. M. P. Panthi and A. G. Singh, “Ethnobotany of Arghakhanchi District, Nepal: plants used in dermatological and cosmetic disorders,” International Journal of Applied Sciences and Biotechnology, vol. 1, no. 2, pp. 27–32, 2013. View at Publisher · View at Google Scholar
  41. A. Kumar, S. Agarwal, A. Singh, and D. Deepak, “Medico-botanical study of some weeds growing in Moradabad District of Western Uttar Pradesh in India,” Indian Journal of Scientific Research, vol. 3, pp. 107–111, 2012. View at Google Scholar
  42. C. R. Sahu, R. K. Nayak, and N. K. Dhal, “Traditional herbal remedies for various diseases used by tribals of Boudh District, Odisha, India for sustainable development,” International Journal of Herbal Medicine, vol. 1, pp. 12–20, 2013. View at Google Scholar
  43. A. K. Saxena, B. Singh, and K. K. Anand, “Hepatoprotective effects of Eclipta alba on subcellular levels in rats,” Journal of Ethnopharmacology, vol. 40, no. 3, pp. 155–161, 1993. View at Publisher · View at Google Scholar · View at Scopus
  44. B. Singh, A. K. Saxena, B. K. Chandan, S. G. Agarwal, and K. K. Anand, “In vivo hepatoprotective activity of active fraction from ethanolic extract of Eclipta alba leaves,” Indian Journal of Physiology and Pharmacology, vol. 45, no. 4, pp. 435–441, 2001. View at Google Scholar · View at Scopus
  45. D. Manvar, M. Mishra, S. Kumar, and V. N. Pandey, “Identification and evaluation of anti hepatitis C virus phytochemicals from Eclipta alba,” Journal of Ethnopharmacology, vol. 144, no. 3, pp. 545–554, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. N. Tabassum and S. S. Agrawal, “Hepatoprotective activity of Eclipta alba Hassk. against paracetamol induced hepatocellular damage in mice,” JK Practitioner, vol. 11, no. 4, pp. 278–280, 2004. View at Google Scholar · View at Scopus
  47. B. Singh, A. K. Saxena, B. K. Chandan, S. G. Agarwal, M. S. Bhatia, and K. K. Anand, “Hepatoprotective effect of ethanolic extract of Eclipta alba on experimental liver damage in rats and mice,” Phytotherapy Research, vol. 7, no. 2, pp. 154–158, 1993. View at Publisher · View at Google Scholar · View at Scopus
  48. R. Vasuki, R. Hari, S. Pandian, and G. Arumugam, “Hepatoprotective action of ethanolic extracts of Eclipta alba and Piper longum linn and their combination on CCL4 induced hepatotoxicity in rats,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 4, no. 1, pp. 455–459, 2012. View at Google Scholar · View at Scopus
  49. K. Prabu, N. Kanchana, and A. M. Sadiq, “Hepatoprotective effect of Eclipta alba on paracetamol induced liver toxicity in rats,” Journal of Microbiology and Biotechnology Research, vol. 1, pp. 75–79, 2011. View at Google Scholar
  50. V. K. Lal, A. Kumar, P. Kumar, and K. S. Yadav, “Screening of leaves and roots of Eclipta alba for hepatoprotective activity,” Archives of Applied Science Research, vol. 2, no. 1, pp. 86–94, 2010. View at Google Scholar
  51. K. Arun and U. Balasubramanian, “Comparative study on hepatoprotective activity of Aegle marmelos and Eclipta alba against alcohol induced in albino rats,” International Journal of Environmental Science, vol. 2, pp. 389–402, 2011. View at Google Scholar
  52. S. R. Parmar, P. H. Vashrambhai, and K. Kalia, “Hepatoprotective activity of some plants extract against paracetamol induced hepatotoxicity in rats,” Journal of Herbal Medicine and Toxicology, vol. 4, pp. 101–106, 2010. View at Google Scholar
  53. K. Kumar, A. K. Katiyar, M. Swamy, Y. P. Sahni, and S. Kumar, “Hepatoprotective effect of Eclipta alba on experimentally induced liver damage in rats,” Indian Journal of Veterinary Pathology, vol. 37, pp. 159–163, 2013. View at Google Scholar
  54. T. Thirumalai, E. David, V. Therasa, and E. K. Elumalai, “Restorative effect of Eclipta alba in CCl4 induced hepatotoxicity in male albino rats,” Asian Pacific Journal of Tropical Disease, vol. 1, no. 4, pp. 304–307, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. K. Narayanasamy and V. Selvi, “Hepatoprotective effect of a polyherbal formulation (Ayush-Liv.04) against ethanol and CCl4 induced liver damage in rats,” Ancient Science of Life, vol. 25, no. 1, pp. 28–33, 2005. View at Google Scholar
  56. M. Kavitha, S. K. Karimulla, D. Kumar, S. Vinoth Kumar, R. Sathish Kumar, and M. Gurucharan, “Hepatoprotective activity ofa poly herbal extract in carbon tetra chloride intoxicated hepatotoxicity in male albino rats,” International Journal of Pharma and Bio Sciences, vol. 2, no. 3, pp. 307–312, 2011. View at Google Scholar · View at Scopus
  57. R. Zafar and B. P. S. Sagar, “Hepatoprotective and cardiac inhibitory activities of ethanolic extracts from plant leaves and leaf callus of Eclipta alba,” Pharmaceutical Biology, vol. 38, no. 5, pp. 357–361, 2000. View at Publisher · View at Google Scholar · View at Scopus
  58. R. K. Roy, M. Thakur, and V. K. Dixit, “Hair growth promoting activity of Eclipta alba in male albino rats,” Archives of Dermatological Research, vol. 300, no. 7, pp. 357–364, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. K. Datta, A. T. Singh, A. Mukherjee, B. Bhat, B. Ramesh, and A. C. Burman, “Eclipta alba extract with potential for hair growth promoting activity,” Journal of Ethnopharmacology, vol. 124, no. 3, pp. 450–456, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. R. M. Thorat, V. M. Jadhav, and V. J. Kadam, “Development and evaluation of polyherbal formulations for hair growth-promoting activity,” International Journal of PharmTech Research, vol. 1, no. 4, pp. 1251–1254, 2009. View at Google Scholar · View at Scopus
  61. S. K. Bhattacharya, K. S. Satyan, and A. Chakrabarti, “Effect of Trasina, an Ayurvedic herbal formulation, on pancreatic islet superoxide dismutase activity in hyperglycaemic rats,” Indian Journal of Experimental Biology, vol. 35, no. 3, pp. 297–299, 1997. View at Google Scholar · View at Scopus
  62. J. Ananthi, A. Prakasam, and K. V. Pugalendi, “Antihyperglycemic activity of Eclipta alba leaf on alloxan-induced diabetic rats,” Yale Journal of Biology and Medicine, vol. 76, no. 1–6, pp. 97–102, 2003. View at Google Scholar · View at Scopus
  63. N. Jaiswal, V. Bhatia, S. P. Srivastava, A. K. Srivastava, and A. K. Tamrakar, “Antidiabetic effect of Eclipta alba associated with the inhibition of α-glucosidase and aldose reductase,” Natural Product Research, vol. 26, no. 24, pp. 2363–2367, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. D. Kumar, R. H. Gaonkar, R. Ghosh, and B. C. Pal, “Bio-assay guided isolation of α-glucosidase inhibitory constituents from Eclipta alba,” Natural Product Communications, vol. 7, no. 8, pp. 989–990, 2012. View at Google Scholar · View at Scopus
  65. P. S. Pandey, K. K. Upadhyay, and D. N. Pandey, “Experimental evaluation of the analgesic property of Eclipta alba (L) Hassk,” Ancient Science of Life, vol. 17, pp. 36–40, 1997. View at Google Scholar
  66. L. K. A. M. Leal, A. A. G. Ferreira, G. A. Bezerra, F. J. A. Matos, and G. S. B. Viana, “Antinociceptive, anti-inflammatory and bronchodilator activities of Brazilian medicinal plants containing coumarin: a comparative study,” Journal of Ethnopharmacology, vol. 70, no. 2, pp. 151–159, 2000. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Sawant, J. C. Isaac, and S. Narayanan, “Analgesic studies on total alkaloids and alcohol extracts of Eclipta alba (Linn.) Hassk,” Phytotherapy Research, vol. 18, no. 2, pp. 111–113, 2004. View at Publisher · View at Google Scholar · View at Scopus
  68. S. S. Kumar, T. Sivakumar, M. J. Chandrasekar, and B. Suresh, “Evaluation of anti-Inflammatory activity of Eclipta alba in rats,” Ancient Science of Life, vol. 24, pp. 112–118, 2005. View at Google Scholar
  69. C. Lans, T. Harper, K. Georges, and E. Bridgewater, “Medicinal plants used for dogs in Trinidad and Tobago,” Preventive Veterinary Medicine, vol. 45, no. 3-4, pp. 201–220, 2000. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Kaur and H. M. Chandola, “Role of rasayana in cure and prevention of recurrence of vicharchika (eczema),” Ayu, vol. 31, no. 1, pp. 33–39, 2010. View at Publisher · View at Google Scholar
  71. C.-F. Chan, W.-Y. Huang, H.-Y. Guo, and B. R. Wang, “Potent antioxidative and UVB protective effect of water extract of Eclipta prostrata L,” The Scientific World Journal, vol. 2014, Article ID 759039, 8 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  72. V. D. Thakur and S. A. Mengi, “Neuropharmacological profile of Eclipta alba (Linn.) Hassk,” Journal of Ethnopharmacology, vol. 102, no. 1, pp. 23–31, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. O. Banji, D. Banji, A. R. Annamalai, and R. Manavalan, “Investigation on the effect of Eclipta alba on animal models of learning and memory,” Indian Journal of Physiology and Pharmacology, vol. 51, no. 3, pp. 274–278, 2007. View at Google Scholar · View at Scopus
  74. O. J. F. Lobo, D. Banji, A. R. Annamalai, and R. Manavalan, “Evaluation of antiaggressive activity of Eclipta alba in experimental animals,” Pakistan Journal of Pharmaceutical Sciences, vol. 21, no. 2, pp. 195–199, 2008. View at Google Scholar · View at Scopus
  75. M. Bhaskar and M. Chintamaneni, “Withania somnifera and Eclipta alba ameliorate oxidative stress induced mitochondrial dysfunction in an animal model of Alzheimer’s disease,” The American Journal of Phytomedicine and Clinical Therapeutics, vol. 2, pp. 140–152, 2014. View at Google Scholar
  76. G. Kaur, R. Tuli, and M. Chintamaneni, “Antioxidant potential of methanolic and hydrolyzed extracts of Eclipta alba,” Pharmacologyonline, vol. 2, pp. 947–956, 2009. View at Google Scholar · View at Scopus
  77. N. Uddin, A. Rahman, N. U. Ahmed, S. Rana, R. Akter, and A. M. M. A. Chowdhury, “Antioxidant, cytotoxic and antimicrobial properties of Eclipta alba ethanol extract,” International Journal of Biological and Medical Research, vol. 1, no. 4, pp. 341–346, 2010. View at Google Scholar
  78. Swati, S. Bedi, and Tanuja, “In vitro antioxidant potential and phytochemical screening of Eclipta alba,” Asian Journal of Experimental Biological Sciences, vol. 3, no. 4, pp. 785–789, 2012. View at Google Scholar
  79. S. Chandan, S. Umesha, and V. Balamurugan, “Antileptospiral, antioxidant and DNA damaging properties of Eclipta alba and Phyllanthus amarus,” Open Access Scientific Reports, vol. 1, pp. 231–238, 2012. View at Google Scholar
  80. A. Baldi, R. Gupta, and M. S. Panwar, “Evaluation of in-vitro antioxidant activity of Eclipta alba,” International Journal of Pharmaceutical and Biological Archive, vol. 2, pp. 767–771, 2011. View at Google Scholar
  81. S. Karthikumar, K. Vigneswari, and K. Jegatheesan, “Screening of antibacterial and antioxidant activities of leaves of Eclipta prostrata (L),” Scientific Research and Essay, vol. 2, no. 4, pp. 101–104, 2007. View at Google Scholar
  82. K. P. Mansoorali, T. Prakash, D. Kotresha, K. Prabhu, and N. Rama Rao, “Cerebroprotective effect of Eclipta alba against global model of cerebral ischemia induced oxidative stress in rats,” Phytomedicine, vol. 19, no. 12, pp. 1108–1116, 2012. View at Publisher · View at Google Scholar · View at Scopus
  83. M. Panghal, V. Kaushal, and J. P. Yadav, “In vitro antimicrobial activity of ten medicinal plants against clinical isolates of oral cancer cases,” Annals of Clinical Microbiology and Antimicrobials, vol. 10, article 21, 2011. View at Publisher · View at Google Scholar · View at Scopus
  84. M. K. Pandey, G. N. Singh, R. K. Sharma, and S. Lata, “Antibacterial activity of Eclipta alba (L.) hassk,” Journal of Applied Pharmaceutical Science, vol. 1, no. 7, pp. 104–107, 2011. View at Google Scholar · View at Scopus
  85. J. Bakht, A. Islam, and M. Shafi, “Antimicrobial potentials of Eclipta alba by well diffusion method,” Pakistan Journal of Botany, vol. 43, pp. 169–174, 2011. View at Google Scholar
  86. P. S. Sandhu, K. Kaur, V. Ahmad et al., “Screening of antimicrobial activity of aqueous extracts of leaves, flower and stem of Eclipta alba,” International Journal of Drug Development and Research, vol. 4, no. 4, pp. 142–147, 2012. View at Google Scholar · View at Scopus
  87. M. K. Peraman, P. Ramalingam, and B. J. N. N. Sai, “Anti-inflammatory and antimicrobial activities of the extracts of Eclipta alba leaves,” European Journal of Experimental Biology, vol. 1, pp. 172–177, 2011. View at Google Scholar
  88. M. Borkataky, B. B. Kakoty, and L. R. Saikia, “Proximate analysis and antimicrobial activity of Eclipta alba (L.) Hassk.—a traditionally used herb,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 5, no. 1, pp. 149–154, 2013. View at Google Scholar · View at Scopus
  89. M. I. S. Saggoo, R. Kaur, and R. C. Gupta, “Comparison of antibacterial activity of three morphotypes of medicinal herb Eclipta alba (L.) Hassk,” Der Pharmacia Lettre, vol. 2, pp. 200–207, 2010. View at Google Scholar
  90. N. Saraswathy and P. M. Kumaran, “Evaluation of aqueous extract of Eclipta alba leaves for preservation potential against Fusarium species,” The American Journal of PharmTech Research, vol. 2, pp. 645–649, 2012. View at Google Scholar
  91. S. Dalal, S. K. Kataria, K. V. Sastry, and S. V. S. Rana, “Phytochemical screening of methanolic extract and antibacterial activity of active principles of hepatoprotective herb, Eclipta alba,” Ethnobotanical Leaflets, vol. 14, pp. 248–258, 2010. View at Google Scholar
  92. A. Ray, P. Bharali, and B. K. Konwar, “Mode of antibacterial activity of eclalbasaponin isolated from Eclipta alba,” Applied Biochemistry and Biotechnology, vol. 171, no. 8, pp. 2003–2019, 2013. View at Publisher · View at Google Scholar · View at Scopus
  93. B. Saroj, A. Shashank, S. Shirshat Mahendra, J. Suryaji, L. S. Patil, and R. A. Deshmukh, “Anti-malarial activity of Eclipta alba against Plasmodium berghei infection in mice,” Journal of Communicable Diseases, vol. 39, no. 2, pp. 91–94, 2007. View at Google Scholar · View at Scopus
  94. M. Govindarajan, “Evaluation of indigenous plant extracts against the malarial vector, Anopheles stephensi (Liston) (Diptera: Culicidae),” Parasitology Research, vol. 109, no. 1, pp. 93–103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  95. M. Govindarajan and P. Karuppannan, “Mosquito larvicidal and ovicidal properties of Eclipta alba (L.) Hassk (Asteraceae) against chikungunya vector, Aedes aegypti (Linn.) (Diptera: Culicidae),” Asian Pacific Journal of Tropical Medicine, vol. 4, no. 1, pp. 24–28, 2011. View at Publisher · View at Google Scholar · View at Scopus
  96. M. Govindarajan and R. Sivakumar, “Adulticidal and repellent properties of indigenous plant extracts against Culex quinquefasciatus and Aedes aegypti (Diptera: Culicidae),” Parasitology Research, vol. 110, no. 5, pp. 1607–1620, 2012. View at Publisher · View at Google Scholar · View at Scopus
  97. M. Govindarajan and R. Sivakumar, “Mosquito adulticidal and repellent activities of botanical extracts against malarial vector, Anopheles stephensi Liston (Diptera: Culicidae),” Asian Pacific Journal of Tropical Medicine, vol. 4, no. 12, pp. 941–947, 2011. View at Publisher · View at Google Scholar · View at Scopus
  98. V. Rangineni, D. Sharada, and S. Saxena, “Diuretic, hypotensive, and hypocholesterolemic effects of Eclipta alba in mild hypertensive subjects: a pilot study,” Journal of Medicinal Food, vol. 10, no. 1, pp. 143–148, 2007. View at Publisher · View at Google Scholar · View at Scopus
  99. D. Christybapita, M. Divyagnaneswari, and R. D. Michael, “Oral administration of Eclipta alba leaf aqueous extract enhances the non-specific immune responses and disease resistance of Oreochromis mossambicus,” Fish and Shellfish Immunology, vol. 23, no. 4, pp. 840–852, 2007. View at Publisher · View at Google Scholar · View at Scopus
  100. M. G. Jayathirtha and S. H. Mishra, “Preliminary immunomodulatory activities of methanol extracts of Eclipta alba and Centella asiatica,” Phytomedicine, vol. 11, no. 4, pp. 361–365, 2004. View at Publisher · View at Google Scholar · View at Scopus
  101. M. F. Shaikh, J. Sancheti, and S. Sathaye, “Phytochemical and pharmacological investigations of Eclipta alba (Linn.) Hassak leaves for antiepileptic activity,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 4, no. 4, pp. 319–323, 2012. View at Google Scholar · View at Scopus
  102. M. F. Shaikh, J. Sancheti, and S. Sathaye, “Effect of Eclipta alba on acute seizure models: A GABAA-mediated effect,” Indian Journal of Pharmaceutical Sciences, vol. 75, no. 3, pp. 380–384, 2013. View at Publisher · View at Google Scholar · View at Scopus
  103. F. Loup, H.-G. Wieser, Y. Yonekawa, A. Aguzzi, and J.-M. Fritschy, “Selective alterations in GABAA receptor subtypes in human temporal lobe epilepsy,” The Journal of Neuroscience, vol. 20, no. 14, pp. 5401–5419, 2000. View at Google Scholar
  104. E. S. C. Pôças, D. V. S. Lopes, A. J. M. da Silva et al., “Structure-activity relationship of wedelolactone analogues: structural requirements for inhibition of Na+,K+-ATPase and binding to the central benzodiazepine receptor,” Bioorganic and Medicinal Chemistry, vol. 14, no. 23, pp. 7962–7966, 2006. View at Publisher · View at Google Scholar · View at Scopus
  105. K. Dirscherl, M. Karlstetter, S. Ebert et al., “Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype,” Journal of Neuroinflammation, vol. 7, article 3, 2010. View at Publisher · View at Google Scholar · View at Scopus
  106. S. Mishra, M. Jena, and S. S. Mishra, “Evaluation of anticonvulsant and muscle relaxant activities of Eclipta alba using animal models,” Indo American Journal of Pharmaceutical Research, vol. 4, pp. 1397–1401, 2014. View at Google Scholar
  107. M. Jena and S. Mishra, “Sedative and antianxiety activity of ethanolic extract of Eclipta alba in albino rats,” International Journal of Pharma and Bio Sciences, vol. 4, no. 4, pp. 1–8, 2013. View at Google Scholar · View at Scopus
  108. D. Sivaraman and P. Muralidaran, “CNS depressant and antiepileptic activities of the methanol extract of the leaves of Ipomoea aquatica forsk,” E-Journal of Chemistry, vol. 7, no. 4, pp. 1555–1561, 2010. View at Publisher · View at Google Scholar · View at Scopus
  109. L. C. Diogo, R. S. Fernandes, S. Marcussi et al., “Inhibition of snake venoms and phospholipases A2 by Extracts from native and genetically modified Eclipta alba: isolation of active coumestans,” Basic and Clinical Pharmacology and Toxicology, vol. 104, no. 4, pp. 293–299, 2009. View at Publisher · View at Google Scholar · View at Scopus
  110. H. Chaudhary, V. Dhuna, J. Singh, S. S. Kamboj, and S. Seshadri, “Evaluation of hydro-alcoholic extract of Eclipta alba for its anticancer potential: an in vitro study,” Journal of Ethnopharmacology, vol. 136, no. 2, pp. 363–367, 2011. View at Publisher · View at Google Scholar · View at Scopus
  111. H. Chaudhary, P. K. Jena, and S. Seshadri, “Evaluation of hydro-alcoholic extract of Eclipta alba for its multidrug resistance reversal potential: an in vitro study,” Nutrition and Cancer, vol. 65, no. 5, pp. 775–780, 2013. View at Publisher · View at Google Scholar · View at Scopus
  112. K. Lirdprapamongkol, J.-P. Kramb, D. Chokchaichamnankit et al., “Juice of Eclipta prostrata inhibits cell migration in vitro and exhibits anti-angiogenic activity in vivo,” In Vivo, vol. 22, no. 3, pp. 363–368, 2008. View at Google Scholar · View at Scopus
  113. N. Chauhan, D. Singh, and R. M. Painuli, “Screening of bioprotective properties and phytochemical analysis of various extracts of Eclipta alba whole plant,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 4, no. 2, pp. 554–560, 2012. View at Google Scholar · View at Scopus
  114. Y. H. Siddique, G. Ara, T. Beg, M. Faisal, and M. Afzal, “Protective role of Eclipta alba L. extract against ethinylestradiol induced genotoxic damage in cultured human lymphocytes,” Alternative Medicine Studies, vol. 1, pp. 14–17, 2011. View at Google Scholar
  115. R. B. Desireddy, G. N. Sowjanya, K. L. L. Reddy, and T. Sowjanya, “Screening of Eclipta alba extracts for anticancer activity,” International Journal of Research and Development in Pharmacy & Life Sciences, vol. 1, pp. 203–205, 2012. View at Google Scholar
  116. M. K. Lee, N. R. Ha, H. Yang, S. H. Sung, G. H. Kim, and Y. C. Kim, “Antiproliferative activity of triterpenoids from Eclipta prostrata on hepatic stellate cells,” Phytomedicine, vol. 15, no. 9, pp. 775–780, 2008. View at Publisher · View at Google Scholar · View at Scopus
  117. S. P. Kumar, B. S. Kumar, V. R. Chandana, M. Vijaykumar, S. K. Ojha, and M. E. Bavani, “Antisecretory and antiulcer activities of Eclipta alba Linn. In rats,” in Proceedings of the 5th World Ayurveda Congress, Oral Presentation, Abstract No. OA01.03, Bhopal, India, December 2012.
  118. A. Banerjee, N. Shrivastava, A. Kothari, H. Padh, and M. Nivsarkar, “Antiulcer activity of methanol extract of Eclipta alba,” Indian Journal of Pharmaceutical Sciences, vol. 67, no. 2, pp. 165–168, 2005. View at Google Scholar · View at Scopus
  119. S. C. Ghule, S. R. Chaudhari, and M. J. Chavan, “Anthelmintic potential of Eclipta alba (L.) Hassk against Pheretima posthuma,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 3, no. 1, pp. 143–144, 2011. View at Google Scholar · View at Scopus
  120. S. D. Bhinge, M. G. Hogade, C. Chavan, M. Kumbhar, and V. Chature, “In vitro anthelmintic activity of herb extract of Eclipta prostrate L. against Pheretima posthuma,” Asian Journal of Pharmaceutical and Clinical Research, vol. 3, no. 3, pp. 229–230, 2010. View at Google Scholar · View at Scopus
  121. H. Wagner and B. Fessler, “In vitro 5-lipoxygenase inhibition by Eclipta alba extracts and the coumestan derivative wedelolactone,” Planta Medica, vol. 5, pp. 374–377, 1986. View at Google Scholar · View at Scopus
  122. E. S. Silverman and J. M. Drazen, “The biology of 5-lipoxygenase: Function, structure, and regulatory mechanisms,” Proceedings of the Association of American Physicians, vol. 111, no. 6, pp. 525–536, 1999. View at Publisher · View at Google Scholar · View at Scopus
  123. S. M. Wong, S. Antus, A. Gottsegen et al., “Wedelolactone and coumestan derivatives as new antihepatotoxic and antiphlogistic principles,” Arzneimittel-Forschung, vol. 38, no. 5, pp. 661–665, 1988. View at Google Scholar · View at Scopus
  124. W. B. Mors, M. C. Do Nascimento, J. P. Parente, M. H. Da Silva, P. A. Melo, and G. Suarez-Kurtz, “Neutralization of lethal and myotoxic activities of south american rattlesnake venom by extracts and constituents of the plant Eclipta prostrata (Asteraceae),” Toxicon, vol. 27, no. 9, pp. 1003–1009, 1989. View at Publisher · View at Google Scholar · View at Scopus
  125. P. A. Melo, M. C. D. Nascimento, W. B. Mors, and G. Suarez-Kurtz, “Inhibition of the myotoxic and hemorrhagic activities of crotalid venoms by Eclipta prostrata (Asteraceae) extracts and constituents,” Toxicon, vol. 32, no. 5, pp. 595–603, 1994. View at Publisher · View at Google Scholar · View at Scopus
  126. P. A. Melo and C. L. Ownby, “Ability of wedelolactone, heparin, and para-bromophenacyl bromide to antagonize the myotoxic effects of two crotaline venoms and their PLA2 myotoxins,” Toxicon, vol. 37, no. 1, pp. 199–215, 1999. View at Publisher · View at Google Scholar · View at Scopus
  127. M. Kobori, Z. Yang, D. Gong et al., “Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibiting the IKK complex,” Cell Death and Differentiation, vol. 11, no. 1, pp. 123–130, 2004. View at Publisher · View at Google Scholar · View at Scopus
  128. F. Yuan, J. Chen, P. P. Sun, S. Guan, and J. Xu, “Wedelolactone inhibits LPS-induced pro-inflammation via NF-κB Pathway in RAW 264.7 cells,” Journal of Biomedical Science, vol. 20, no. 1, article 84, 2013. View at Publisher · View at Google Scholar · View at Scopus
  129. S. Tewtrakul, S. Subhadhirasakul, S. Cheenpracha, and C. Karalai, “HIV-1 protease and HIV-1 integrase inhibitory substances from Eclipta prostrata,” Phytotherapy Research, vol. 21, no. 11, pp. 1092–1095, 2007. View at Publisher · View at Google Scholar · View at Scopus
  130. F.-M. Lin, L.-R. Chen, E.-H. Lin et al., “Compounds from Wedelia chinensis synergistically suppress androgen activity and growth in prostate cancer cells,” Carcinogenesis, vol. 28, no. 12, pp. 2521–2529, 2007. View at Publisher · View at Google Scholar · View at Scopus
  131. P. Benes, L. Knopfova, F. Trcka et al., “Inhibition of topoisomerase IIα: novel function of wedelolactone,” Cancer Letters, vol. 303, no. 1, pp. 29–38, 2011. View at Publisher · View at Google Scholar · View at Scopus
  132. W. M. Huston, S. Gloeckl, L. de Boer, K. W. Beagley, and P. Timms, “Apoptosis is induced in Chlamydia trachomatis-infected HEp-2 cells by the addition of a combination innate immune activation compounds and the inhibitor wedelolactone,” The American Journal of Reproductive Immunology, vol. 65, no. 5, pp. 460–465, 2011. View at Publisher · View at Google Scholar · View at Scopus
  133. H. Deng and Y. Fang, “Anti-inflammatory gallic acid and wedelolactone are G protein-coupled receptor-35 agonists,” Pharmacology, vol. 89, no. 3-4, pp. 211–219, 2012. View at Publisher · View at Google Scholar · View at Scopus
  134. S.-W. Qian, X. Li, Y.-Y. Zhang et al., “Characterization of adipocyte differentiation from human mesenchymal stem cells in bone marrow,” BMC Developmental Biology, vol. 10, article 47, 2010. View at Publisher · View at Google Scholar · View at Scopus
  135. S. Lim, H.-J. Jang, E. H. Park et al., “Wedelolactone inhibits adipogenesis through the ERK pathway in human adipose tissue-derived mesenchymal stem cells,” Journal of Cellular Biochemistry, vol. 113, no. 11, pp. 3436–3445, 2012. View at Publisher · View at Google Scholar · View at Scopus
  136. S. Sarveswaran, S. C. Gautam, and J. Ghosh, “Wedelolactone, a medicinal plant-derived coumestan, induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt,” International Journal of Oncology, vol. 41, no. 6, pp. 2191–2199, 2012. View at Publisher · View at Google Scholar · View at Scopus
  137. D. N. Dhanasekaran and E. P. Reddy, “JNK signaling in apoptosis,” Oncogene, vol. 27, no. 48, pp. 6245–6251, 2008. View at Publisher · View at Google Scholar · View at Scopus
  138. A. G. Porter and R. U. Jänicke, “Emerging roles of caspase-3 in apoptosis,” Cell Death and Differentiation, vol. 6, no. 2, pp. 99–104, 1999. View at Publisher · View at Google Scholar · View at Scopus
  139. H. Okhrimenko, W. Lu, C. Xiang, N. Hamburger, G. Kazimirsky, and C. Brodie, “Protein kinase C-ε regulates the apoptosis and survival of glioma cells,” Cancer Research, vol. 65, no. 16, pp. 7301–7309, 2005. View at Publisher · View at Google Scholar · View at Scopus
  140. Z. Chen, X. Sun, S. Shen et al., “Wedelolactone, a naturally occurring coumestan, enhances interferon-γ signaling through inhibiting STAT1 protein dephosphorylation,” Journal of Biological Chemistry, vol. 288, no. 20, pp. 14417–14427, 2013. View at Publisher · View at Google Scholar · View at Scopus
  141. A. Stephanou and D. S. Latchman, “STAT-1: a novel regulator of apoptosis,” International Journal of Experimental Pathology, vol. 84, no. 6, pp. 239–244, 2003. View at Publisher · View at Google Scholar · View at Scopus
  142. Y. Xia, J. Chen, Y. Cao et al., “Wedelolactone exhibits anti-fibrotic effects on human hepatic stellate cell line LX-2,” European Journal of Pharmacology, vol. 714, no. 1–3, pp. 105–111, 2013. View at Publisher · View at Google Scholar · View at Scopus
  143. Q. M. Liu, H. Y. Zhao, X. K. Zhong, and J. G. Jiang, “Eclipta prostrata L. phytochemicals: Isolation, structure elucidation, and their antitumor activity,” Food and Chemical Toxicology, vol. 50, no. 11, pp. 4016–4022, 2012. View at Publisher · View at Google Scholar · View at Scopus
  144. S. Ryu, J.-S. Shin, J. Y. Jung et al., “Echinocystic acid isolated from Eclipta prostrata suppresses Lipopolysaccharide-induced iNOS, TNF- α, and IL-6 expressions via NF-κ B inactivation in RAW 2647 macrophages,” Planta Medica, vol. 79, no. 12, pp. 1031–1037, 2013. View at Publisher · View at Google Scholar · View at Scopus
  145. G. Kweifio-Okai and T. A. Macrides, “Antilipoxygenase activity of amyrin triterpenes,” Research Communications in Chemical Pathology and Pharmacology, vol. 78, no. 3, pp. 367–372, 1992. View at Google Scholar · View at Scopus
  146. G. Kweifio-Okai, D. Bird, P. Eu, A. R. Carroll, R. Ambrose, and B. Field, “Effect of α-amyrin palmitate on adjuvant arthritis,” Drugs under Experimental and Clinical Research, vol. 20, no. 1, pp. 1–5, 1994. View at Google Scholar · View at Scopus
  147. G. Kweifio-Okai, F. De Munk, B. A. Rumble, T. A. Macrides, and M. Cropley, “Antiarthritic mechanisms of amyrin triterpenes,” Research Communications in Molecular Pathology and Pharmacology, vol. 85, no. 1, pp. 45–55, 1994. View at Google Scholar · View at Scopus
  148. M. F. Otuki, J. Ferreira, F. V. Lima et al., “Antinociceptive properties of mixture of α-amyrin and β-amyrin triterpenes: evidence for participation of protein kinase C and protein kinase A pathways,” Journal of Pharmacology and Experimental Therapeutics, vol. 313, no. 1, pp. 310–318, 2005. View at Publisher · View at Google Scholar · View at Scopus
  149. M. F. Otuki, F. Vieira-Lima, Â. Malheiros, R. A. Yunes, and J. B. Calixto, “Topical antiinflammatory effects of the ether extract from Protium kleinii and α-amyrin pentacyclic triterpene,” European Journal of Pharmacology, vol. 507, no. 1–3, pp. 253–259, 2005. View at Publisher · View at Google Scholar · View at Scopus
  150. R. Medeiros, M. F. Otuki, M. C. W. Avellar, and J. B. Calixto, “Mechanisms underlying the inhibitory actions of the pentacyclic triterpene α-amyrin in the mouse skin inflammation induced by phorbol ester 12-O-tetradecanoylphorbol-13-acetate,” European Journal of Pharmacology, vol. 559, no. 2-3, pp. 227–235, 2007. View at Publisher · View at Google Scholar · View at Scopus
  151. C. M. Melo, T. C. Morais, A. R. Tomé et al., “Anti-inflammatory effect of α,β-amyrin, a triterpene from Protium heptaphyllum, on cerulein-induced acute pancreatitis in mice,” Inflammation Research, vol. 60, no. 7, pp. 673–681, 2011. View at Publisher · View at Google Scholar · View at Scopus
  152. C. M. Melo, K. M. M. B. Carvalho, J. C. de Sousa Neves et al., “α,β-amyrin, a natural triterpenoid ameliorates L-arginine-induced acute pancreatitis in rats,” World Journal of Gastroenterology, vol. 16, no. 34, pp. 4272–4280, 2010. View at Publisher · View at Google Scholar · View at Scopus
  153. F. A. Oliveira, C. L. S. Costa, M. H. Chaves et al., “Attenuation of capsaicin-induced acute and visceral nociceptive pain by α- and β-amyrin, a triterpene mixture isolated from Protium heptaphyllum resin in mice,” Life Sciences, vol. 77, no. 23, pp. 2942–2952, 2005. View at Publisher · View at Google Scholar · View at Scopus
  154. R. C. P. Lima Jr., F. A. Oliveira, L. A. Gurgel et al., “Attenuation of visceral nociception by α- and β- amyrin, a triterpenoid mixture isolated from the resin of Protium heptaphyllum, in mice,” Planta Medica, vol. 72, no. 1, pp. 34–39, 2006. View at Publisher · View at Google Scholar · View at Scopus
  155. C. E. Vitor, C. P. Figueiredo, D. B. Hara, A. F. Bento, T. L. Mazzuco, and J. B. Calixto, “Therapeutic action and underlying mechanisms of a combination of two pentacyclic triterpenes, αand β-amyrin, in a mouse model of colitis,” British Journal of Pharmacology, vol. 157, no. 6, pp. 1034–1044, 2009. View at Publisher · View at Google Scholar · View at Scopus
  156. I. Matos, A. F. Bento, R. Marcon, R. F. Claudino, and J. B. Calixto, “Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: the relevance of cannabinoid system,” Molecular Immunology, vol. 54, no. 3-4, pp. 482–492, 2013. View at Publisher · View at Google Scholar · View at Scopus
  157. N. Ali, “Brine shrimp cytotoxicity of crude methanol extract and antispasmodic activity of α-amyrin acetate from Tylophora hirsuta Wall,” BMC Complementary and Alternative Medicine, vol. 13, article 135, 2013. View at Publisher · View at Google Scholar · View at Scopus
  158. F. A. Santos, J. T. Frota, B. R. Arruda et al., “Antihyperglycemic and hypolipidemic effects of α,β-amyrin, a triterpenoid mixture from Protium heptaphyllum in mice,” Lipids in Health and Disease, vol. 11, article 98, 2012. View at Publisher · View at Google Scholar · View at Scopus
  159. A. B. Singh, D. K. Yadav, R. Maurya, and A. K. Srivastava, “Antihyperglycaemic activity of α-amyrin acetate in rats and db/db mice,” Natural Product Research, vol. 23, no. 9, pp. 876–882, 2009. View at Publisher · View at Google Scholar · View at Scopus
  160. E. Biskup, M. Golebiowski, R. Gniadecki, P. Stepnowski, and E. Lojkowska, “Triterpenoid α-amyrin stimulates proliferation of human keratinocytes but does not protect them against UVB damage,” Acta Biochimica Polonica, vol. 59, no. 2, pp. 255–260, 2012. View at Google Scholar · View at Scopus
  161. K. Chenniappan and M. Kadarkari, “Adult mortality and blood feeding behavioral effects of α-amyrin acetate, a novel bioactive compound on in vivo exposed females of Anopheles stephensi liston (Diptera: Culicidae),” Parasitology Research, vol. 110, no. 6, pp. 2117–2124, 2012. View at Publisher · View at Google Scholar · View at Scopus
  162. G. F. Aragão, L. M. V. Carneiro, A. P. F. Junior et al., “A possible mechanism for anxiolytic and antidepressant effects of α- and β-amyrin from Protium heptaphyllum (Aubl.) March,” Pharmacology Biochemistry and Behavior, vol. 85, no. 4, pp. 827–834, 2006. View at Publisher · View at Google Scholar · View at Scopus
  163. F. A. Oliveira, M. H. Chaves, F. R. C. Almeida et al., “Protective effect of α- And β-amyrin, a triterpene mixture from Protium heptaphyllum (Aubl.) March. trunk wood resin, against acetaminophen-induced liver injury in mice,” Journal of Ethnopharmacology, vol. 98, no. 1-2, pp. 103–108, 2005. View at Publisher · View at Google Scholar · View at Scopus
  164. F. A. Oliveira, G. M. Vieira Jr., M. H. Chaves et al., “Gastroprotective effect of the mixture of α- and β-amyrin from Protium heptaphyllum: role of capsaicin-sensitive primary afferent neurons,” Planta Medica, vol. 70, no. 8, pp. 780–782, 2004. View at Publisher · View at Google Scholar · View at Scopus
  165. F. A. Oliveira, R. C. P. Lima-Junior, W. M. Cordeiro et al., “Pentacyclic triterpenoids, α,β-amyrins, suppress the scratching behavior in a mouse model of pruritus,” Pharmacology Biochemistry and Behavior, vol. 78, no. 4, pp. 719–725, 2004. View at Publisher · View at Google Scholar · View at Scopus
  166. J. M. Castellano, A. Guinda, T. Delgado, M. Rada, and J. A. Cayuela, “Biochemical basis of the antidiabetic activity of oleanolic acid and related pentacyclic triterpenes,” Diabetes, vol. 62, no. 6, pp. 1791–1799, 2013. View at Publisher · View at Google Scholar · View at Scopus
  167. K. N. Lewis, J. Mele, J. D. Hayes, and R. Buffenstein, “Nrf2, a guardian of healthspan and gatekeeper of species longevity,” Integrative and Comparative Biology, vol. 50, no. 5, pp. 829–843, 2010. View at Publisher · View at Google Scholar · View at Scopus
  168. M. K. Shanmugam, X. Dai, A. P. Kumar, B. K. Tan, G. Sethi, and A. Bishayee, “Oleanolic acid and its synthetic derivatives for the prevention and therapy of cancer: preclinical and clinical evidence,” Cancer Letters, vol. 346, pp. 206–216, 2014. View at Publisher · View at Google Scholar
  169. Y. Ikeda, A. Murakami, and H. Ohigashi, “Ursolic acid: an anti- and pro-inflammatory triterpenoid,” Molecular Nutrition and Food Research, vol. 52, no. 1, pp. 26–42, 2008. View at Publisher · View at Google Scholar · View at Scopus
  170. N. Sultana, “Clinically useful anticancer, antitumor, and antiwrinkle agent, ursolic acid and related derivatives as medicinally important natural product,” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 26, no. 5, pp. 616–642, 2011. View at Publisher · View at Google Scholar · View at Scopus
  171. J. Liu, “Pharmacology of oleanolic acid and ursolic acid,” Journal of Ethnopharmacology, vol. 49, no. 2, pp. 57–68, 1995. View at Publisher · View at Google Scholar · View at Scopus
  172. K.-Y. Yoo and S.-Y. Park, “Terpenoids as potential anti-Alzheimer's disease therapeutics,” Molecules, vol. 17, no. 3, pp. 3524–3538, 2012. View at Publisher · View at Google Scholar · View at Scopus
  173. L.-L. Zang, B.-N. Wu, Y. Lin, J. Wang, L. Fu, and Z.-Y. Tang, “Research progress of ursolic acid's anti-tumor actions,” Chinese Journal of Integrative Medicine, vol. 20, no. 1, pp. 72–79, 2014. View at Publisher · View at Google Scholar · View at Scopus
  174. X. Chen, G. A. Müller, M. Quaas et al., “The forkhead transcription factor FOXM1 controls cell cycle-dependent gene expression through an atypical chromatin binding mechanism,” Molecular and Cellular Biology, vol. 33, no. 2, pp. 227–236, 2013. View at Publisher · View at Google Scholar · View at Scopus
  175. C. Yang, H. Chen, L. Yu et al., “Inhibition of FOXM1 transcription factor suppresses cell proliferation and tumor growth of breast cancer,” Cancer Gene Therapy, vol. 20, no. 2, pp. 117–124, 2013. View at Publisher · View at Google Scholar · View at Scopus
  176. G. Seelinger, I. Merfort, and C. M. Schempp, “Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin,” Planta Medica, vol. 74, no. 14, pp. 1667–1677, 2008. View at Publisher · View at Google Scholar · View at Scopus
  177. G. Seelinger, I. Merfort, U. Wölfle, and C. M. Schempp, “Anti-carcinogenic effects of the flavonoid luteolin,” Molecules, vol. 13, no. 10, pp. 2628–2651, 2008. View at Publisher · View at Google Scholar · View at Scopus
  178. Y. Lin, R. Shi, X. Wang, and H.-M. Shen, “Luteolin, a flavonoid with potential for cancer prevention and therapy,” Current Cancer Drug Targets, vol. 8, no. 7, pp. 634–646, 2008. View at Publisher · View at Google Scholar · View at Scopus
  179. M. López-Lázaro, “Distribution and biological activities of the flavonoid luteolin,” Mini-Reviews in Medicinal Chemistry, vol. 9, no. 1, pp. 31–59, 2009. View at Publisher · View at Google Scholar · View at Scopus
  180. X. Tongda, D. Li, and D. Jiang, “Targeting cell signaling and apoptotic pathways by luteolin: cardioprotective role in rat cardiomyocytes following ischemia/reperfusion,” Nutrients, vol. 4, no. 12, pp. 2008–2019, 2012. View at Publisher · View at Google Scholar · View at Scopus
  181. D. Patel, S. Shukla, and S. Gupta, “Apigenin and cancer chemoprevention: progress, potential and promise (review),” International Journal of Oncology, vol. 30, no. 1, pp. 233–245, 2007. View at Google Scholar · View at Scopus
  182. S. Shukla and S. Gupta, “Apigenin: a promising molecule for cancer prevention,” Pharmaceutical Research, vol. 27, no. 6, pp. 962–978, 2010. View at Publisher · View at Google Scholar · View at Scopus
  183. M. Piantelli, C. Rossi, M. Iezzi et al., “Flavonoids inhibit melanoma lung metastasis by impairing tumor cells endothelium interactions,” Journal of Cellular Physiology, vol. 207, no. 1, pp. 23–29, 2006. View at Publisher · View at Google Scholar · View at Scopus
  184. L. Wang, L. Kuang, J. A. Hitron et al., “Apigenin suppresses migration and invasion of transformed cells through down-regulation of C-X-C chemokine receptor 4 expression,” Toxicology and Applied Pharmacology, vol. 272, no. 1, pp. 108–116, 2013. View at Publisher · View at Google Scholar · View at Scopus
  185. É. C. Lefort and J. Blay, “Apigenin and its impact on gastrointestinal cancers,” Molecular Nutrition and Food Research, vol. 57, no. 1, pp. 126–144, 2013. View at Publisher · View at Google Scholar · View at Scopus
  186. Y.-Y. Bao, S.-H. Zhou, J. Fan, and Q.-Y. Wang, “Anticancer mechanism of apigenin and the implications of GLUT-1 expression in head and neck cancers,” Future Oncology, vol. 9, no. 9, pp. 1353–1364, 2013. View at Publisher · View at Google Scholar · View at Scopus